Bioventus LLC
17
0
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
23.5%
4 terminated/withdrawn out of 17 trials
66.7%
-19.8% vs industry average
6%
1 trials in Phase 3/4
75%
6 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Observational, Non-interventional Use of LIPUS to Mitigate Fracture Non-union in Patients at Risk
Role: lead
Study of StimRouter for Chronic Knee OA Pain
Role: lead
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
Role: lead
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
Role: lead
Scaphoid Non-union and Low-intensity Pulsed Ultrasound Trial
Role: collaborator
Safety Study of PTP-001 for Treating Knee Osteoarthritis
Role: lead
Durolane SJ for Treatment of Rhizarthrosis
Role: collaborator
SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder
Role: lead
Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoarthritis Pain
Role: lead
Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery
Role: lead
Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA
Role: lead
Prospective Single Center Open Label Study of Shoulder OA Pain
Role: lead
A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Role: lead
26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle
Role: lead
Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee
Role: lead
Trial to Evaluate UltraSound in the Treatment of Tibial Fractures
Role: lead
Randomized Trial in knEe Osteoarthritis Using Low Intensity Ultrasound - Evaluating Feasibility (RELIEF)
Role: collaborator
All 17 trials loaded